PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Azithromycin Affords Neuroprotection in Rat Undergone Transient Focal Cerebral Ischemia.

Rat / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31849581 ↗2019Reported benefit

Azithromycin Affords Neuroprotection in Rat Undergone Transient Focal Cerebral Ischemia.

RatIschaemia-reperfusionCerebral (MCAO/stroke)WistarMalen = 4 to 6 animals per experimental group (4 per group for West…Intraperitoneal0.15 to 150 mg/kg for the dose-response study (ED50 1.40 mg…Administered upon reperfusion, that is after 2 h of middle cerebral artery occl…

Model: Transient focal cerebral ischaemia by intraluminal filament occlusion of the middle cerebral artery for 2 h (or 4.5 h in the time-window experiment) followed by reperfusion

A single dose reduced ischaemic brain damage dose-dependently, cut oedema at 22 h of reperfusion (vehicle 85.7 plus or minus 19.9 mm3 versus azithromycin 25.2 plus or minus 9.6 mm3), reduced infarct volume and neurological deficit up to 7 days, remained effective when given after 4.5 h of occlusion…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.95. Machine-extracted fields require source verification.